Management buys out Sunrise Medical:
This article was originally published in Clinica
An investor group including its CEO Michael Hammers and other senior managers is leading a management buyout of Sunrise Medical, for $10 per share, representing a 79% premium on the average closing share price over the past 60 days. Bankers Trust, a wholly-owned subsidiary of Deutsche Bank, the company's existing lender, will provide $215 million in bank debt and $40 million in subordinated debt. The Carlsbad, California company makes respiratory aids and healthcare equipment such as special beds and wheelchairs.